BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

BXPHARMA

All Eps Dividend Board Agm Q1 Q2 Q3

BXPHARMA 14-May-2015

(Q1 Un-audited): Profit after tax from Jan'15 to March'15 was Tk. 406.71 million with basic EPS of Tk. 1.11 as against Tk. 329.78 million and Tk. 0.90 respectively for the same period of the previous year. However, considering proposed bonus share @ 5% for the year 2014, restated basic EPS will be Tk. 1.05 as on 31.03.2015 and Tk. 0.85 as on 31.03.2014.

BXPHARMA 29-Apr-2015

There will be no price limit on the trading of the shares of the Company today (29.04.2015) following its corporate declaration.

BXPHARMA 29-Apr-2015

The Board of Directors has recommended 10% cash dividend and 5% stock dividend for the year ended on December 31, 2014. Date of AGM: 13.06.2015, Time: 10:30 AM, Venue: Beximco Industrial Park, Sarabo, Kashimpur, Gazipur. Record Date: 21.05.2015. The Company has also reported EPS of Tk. 4.15, NAV per share of Tk. 56.87 and NOCFPS of Tk. 6.03 for the year ended on December 31, 2014.

BXPHARMA 23-Apr-2015

As per Regulation 30 of DSE Listing Regulations, the Company has informed that a meeting of the Board of Directors will be held on April 27, 2015 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended on December 31, 2014.

BXPHARMA 28-Jan-2015

(continuation of news of BXPHARMA): will be drawn down in four tranches against delivery and installation of the plant and machinery commencing now and due for completion in June 2016, with commissioning to be completed by September 2016. The Loan will attract interest at the rate of 2.25% per annum above LIBOR; in addition, the Lender will receive management fees and commitment fees. Repayment will be made over five years, in 10 semi-annual payments commencing for US $5.597 million from the (cont.2)

BXPHARMA 28-Jan-2015

(continuation of news of BXPHARMA): earlier of six months after delivery and Installation or 15 January 2016, with repayment of the balance commencing from the earlier of six months after commissioning or 30 March 2017.The Loan Agreement, the terms of which were agreed by the Company and the Lender in December 2014, was subject to formal approval by the Board of Investment, Bangladesh. The BOI in its meeting held on 20 January, 2015 has approved the agreement. (end)

BXPHARMA 28-Jan-2015

The Company has informed that it has entered into a new Loan Agreement with BHF-Bank Aktiengesellshaft, Frankfurt, Germany to borrow up to US $51.559 million to partially finance the purchase of new plant and machinery to expand its production facilities; it will be covered by Hermes (German Export Credit Agency Euler Hermes Aktiengesellshaft, Hamburg) guarantee. The Loan, which is secured on the plant and machinery being purchased, (cont.1)

BXPHARMA 08-Dec-2014

Credit Rating Information and Services Limited (CRISL) has rated the Company as "AA-" in the long term and "ST-2" in the short term along with a stable outlook based on audited financial statements of the Company up to December 31, 2013, unaudited financials up to September 30, 2014 and other relevant quantitative as well as qualitative information up to the date of rating declaration.

BXPHARMA 30-Oct-2014

(Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 30th September 2014 (July'14 to Sep'14), the Company has reported net profit after tax of Tk. 429.76 million with EPS of Tk. 1.17 as against Tk. 424.68 million and Tk. 1.15 respectively for the same period of the previous year. Whereas net profit after tax was Tk. 1,154.03 million with EPS of Tk. 3.14 for the period of nine months (Jan'14 to Sep'14) ended on 30.09.2014 as against Tk. 1,083.18 million and Tk. 2.94 respectively for the same period of the previous year.

BXPHARMA 14-Jul-2014

The Company has informed that cash dividend for the year 2013 has been credited to the respective shareholders' Bank Accounts under their BO Accounts through BEFTN System.

Previous Next page